Qiagen NV - Company Profile
Powered by 
All the sales intelligence you need on Qiagen NV in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Qiagen NV fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Qiagen NV.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Qiagen NV is a life-science and diagnostics company that helps laboratories turn biological samples into clear test results and research insights. The company’s product portfolio includes the collection, stabilization, and purification of DNA, RNA, and proteins from materials such as blood and tissue. Qiagen offers tools and kits for key lab steps like PCR testing, sequencing, and studying gene activity and epigenetics, plus specialized solutions for exosomes and circulating tumor cells. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical, biotechnology and life sciences research markets. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.
Headquarters
Netherlands
Address
Hulsterweg 82, Venlo, 5912PL
Website
www.qiagen.com
Telephone
31 77 3556600
No of Employees
5,654
Industry
Medical Equipment
Ticker Symbol & Exchange
QGEN (NYSE)
Revenue (2024)
$2.1B
5.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
408.3%
(2024 vs 2023)
Market Cap*
$8.5B
Net Profit Margin (2024)
XYZ
380.6%
(2024 vs 2023)
* As of and is in US$
Qiagen NV premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Discovery and Translational Research | Service Solutions | CPT |
| DNA & RNA Purification | Bioinformatics Services | Qiagen |
| Protein Purification | QuantiFERON | |
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In November, the company entered into an agreement to acquire Parse Biosciences, a biotechnology company. |
| 2025 | New Products/Services | In October, the company introduced the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution. |
| 2025 | New Products/Services | In September, the company introduced QIAstat‑Dx Rise, a version of the QIAstat-Dx automated syndromic testing system. |
Competitor Comparison
| Key Parameters | Qiagen NV | Thermo Fisher Scientific Inc | Illumina Inc | MilliporeSigma | Promega Corp |
|---|---|---|---|---|---|
| Headquarters | Netherlands | United States of America | United States of America | United States of America | United States of America |
| City | Venlo | Waltham | San Diego | Burlington | Madison |
| State/Province | - | Massachusetts | California | Massachusetts | Wisconsin |
| No. of Employees | 5,654 | 125,000 | 8,600 | 9,000 | 2,200 |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stephen H. Rusckowski | Chairman | Executive Board | 2025 | 69 |
| Thierry Bernard | Chief Executive Officer; Managing Director | Senior Management | 2020 | 62 |
| Roland Sackers | Managing Director; Chief Financial Officer | Senior Management | 1999 | - |
| Nitin Sood | Senior Vice President; Head - Product Portfolio & Innovation | Senior Management | 2025 | - |
| Fernando Beils | Head - Global Commercial Operations; Senior Vice President | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer